Invention Grant
- Patent Title: Ecdysone receptor-based inducible gene expression system
- Patent Title (中): 基于蜕皮激素受体的诱导型基因表达系统
-
Application No.: US13463527Application Date: 2012-05-03
-
Publication No.: US08822754B2Publication Date: 2014-09-02
- Inventor: Subba Reddy Palli , Marianna Zinovjevna Kapitskaya , Dean Ervin Cress
- Applicant: Subba Reddy Palli , Marianna Zinovjevna Kapitskaya , Dean Ervin Cress
- Applicant Address: US VA Blacksburg
- Assignee: Intrexon Corporation
- Current Assignee: Intrexon Corporation
- Current Assignee Address: US VA Blacksburg
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: A01K67/00
- IPC: A01K67/00 ; A01K67/033 ; A01K67/027

Abstract:
This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
Public/Granted literature
- US20120322148A1 Novel Ecdysone Receptor-Based Inducible Gene Expression System Public/Granted day:2012-12-20
Information query